SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following an earnings report that eased AI bubble fears and showcased strong revenue growth, particularly in its data center segment. The community is debating the sustainability of this growth, questioning accounting practices and revenue recognition, while also anticipating potential impact from a White House request regarding chip exports to China. Bullish sentiment prevails, with some analysts predicting further climbs, while others remain cautious, citing macro risks.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is trending as community members highlight its strong performance against $INJ and its potential for significant gains, particularly with the anticipated Injective EVM mainnet launch. Discussions revolve around its dedicated community, high burned liquidity, and successful NFT collections as key factors. Many community members believe $NONJA is the best way to leverage the $INJ ecosystem.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

Safe & Green Holdings is experiencing significant attention due to discussions around a potential short squeeze, driven by alleged high short interest and low float. The stock's volatility is attracting community members who are drawing parallels to previous short squeeze events and anticipating further upward momentum, while others are wary of a potential pullback. Discussions about a potential merger are being discussed as a catalyst for the stock.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

EOSE is trending due to recent financing moves and heavy short interest, leading to community discussions about potential short squeezes and rallies. Investors are closely watching for the release of the offering price and its impact on dilution, as well as the company's role in energy storage amid increasing AI data center power demands. Positive sentiment is fueled by institutional investment and strategic partnerships.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective (INJ) is trending due to community excitement around the potential of leveraging its ecosystem with memecoins, specifically $NONJA. The community believes $NONJA offers high liquidity and upside potential, acting as a leveraged bet on the broader INJ ecosystem. This strategy is driven by the perception that memes on Injective move quickly and can offer outsized returns.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Recent discussion around CRWV is largely focused on a potential sympathy play following strong earnings from NVDA, with many anticipating a short squeeze. Community sentiment is mixed, with some citing the company's debt and potential for high growth, while others highlight potential overvaluation and supply chain concerns. Michael Burry's past comments on GPU depreciation are also being debated in relation to CRWV's prospects.

ETF Opportunities Trust - T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Long NVIDIA Daily Target ETF ($NVDX) is trending amid discussions around NVIDIA's earnings and its impact on the AI ecosystem. The community is actively analyzing earnings results, strategizing trades with leveraged ETFs, and debating future movements. Bullish sentiment is fueled by confidence in NVIDIA's long-term growth and dominance in the AI sector, while some traders express caution regarding the ETF's decay and potential market volatility.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Blockchain Inc

Riot Blockchain is trending amid discussions around its oversold conditions and potential for a short-term rebound, with some traders eyeing entry points and targets based on moving averages. Community members are actively debating the impact of Nvidia's performance on the broader market sentiment and the trajectory of Bitcoin and AI-related stocks. Additionally, there's anticipation for news regarding data center partnerships, which some believe could be a significant catalyst for the stock.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx is trending as community members assess the impact of new coverage from Piper Sandler and Canaccord Genuity, with price targets ranging from $155-$160. Recent news and strong earnings have generated discussion around the company's growth potential and possible disruptor status, while some traders are closely watching the chart setup for potential breakout opportunities and technical brilliance. Meanwhile, other investors are evaluating its high valuation and potential issues related to profitability and Medicaid.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals ($AGIO) is trending downwards after mixed results from its sickle cell disease drug trial sparked uncertainty about its regulatory path, leading to a significant stock plunge. Bullish analysts are split with some citing precedent for FDA approval, while the community debates the impact of missed endpoints and considers potential opportunities for competitors. Discussions also involve the company's cash position and upcoming PDUFA date for thalassemia.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It offers Epifractan and CannabiPiel. The company was founded on 26th October, 1988 and is headquartered in Toronto, Canada.

RAMMF
RAMM Pharma Corp

Feed

News

Sentiment

Fundamentals

Info

Latest RAMMF News

RAMMFRAMM Pharma Corp